Prevention and intervention strategies for substance use disorder

  • Priya Sharma
Keywords: Substance use disorder, telehealth, peer support, pharmacogenomics, treatment innovation.

Abstract

Substance use disorder (SUD) is still a major global health problem, for which traditional prevention and intervention are often hindered by access, stigmatization, and social structures. New opportunities like telehealth, peer support, and pharmacogenomics present themselves as possibilities for raising the outcomes of treatment and increasing accessibility. This review examines novel trends in the prevention and treatment of SUDs for the last decade, which include telehealth and virtual treatment, peer support and recovery coaching, and pharmacogenomics. Research from scholarly databases is reviewed to analyze the effectiveness of these strategies and the potential for increasing the availability of treatment services. Telehealth is useful in overcoming geographical and stigmatization barriers to care and in affording patients access to treatment. Several peer support interventions have been shown to have a beneficial influence on treatment participation as well as recovery. Pharmacogenomics has been advanced as a useful way to tailor pharmacological therapies to genetic differences, which may increase effectiveness and decrease relapse. Despite these gaps in knowledge territory showing such promising emerging trends to SUD treatment, challenges like stigma, access to resources, and funding gaps keep on existing. More investigation should be carried out in the future about such innovations and their impact and the policy agendas should aim at increasing the adoption of such methods into the conventional systems of treatment.

Author Biography

Priya Sharma

Research Scholar, Shambhu Dayal (PG) College,

References

1. Abdollahpour, S., Ramezani, S., & Khosravi, A. (2015). Perceived social support among family in pregnant women.
2. Abuse, S. (2020). Key substance use and mental health indicators in the United States: results from the 2019 National Survey on Drug Use and Health.
3. Acharibasam, J. W., & Wynn, R. (2018). Telemental Health in Low‐and Middle‐Income Countries: A Systematic Review. International Journal of Telemedicine and Applications, 2018(1), 9602821.
4. Baird, C. (2016). Recovery Management and Recovery-Oriented Systems of Care. Journal of Addictions Nursing, 27(2), 151-153.
5. Breijyeh, Z., Jubeh, B., Bufo, S. A., Karaman, R., & Scrano, L. (2021). Cannabis: a toxin-producing plant with potential therapeutic uses. Toxins, 13(2), 117.
6. Barlow, D. H., Allen, L. B., & Choate, M. L. (2020). Toward a unified treatment for emotional disorders. In The Neurotic Paradox, Volume 1 (pp. 141-166). Routledge.
7. Bashshur, R. L., Howell, J. D., Krupinski, E. A., Harms, K. M., Bashshur, N., & Doarn, C. R. (2016). The empirical foundations of telemedicine interventions in primary care. Telemedicine and e-Health, 22(5), 342-375.
8. Bauer, I. E., Soares, J. C., & Nielsen, D. A. (2015). The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: a systematic review. The American Journal on Addictions, 24(1), 15-23.
9. Bonk, R., Miller, R. J., Lanter, J., Niblo, C., Kemp, J., & Shelton, J. (2020). Accidental overdose deaths in Oklahoma, 2002–2017: Opioid and methamphetamine trends. Journal of Analytical Toxicology, 44(7), 672-678.
10. Carra, M. C., Detzen, L., Kitzmann, J., Woelber, J. P., Ramseier, C. A., & Bouchard, P. (2020). Promoting behavioral changes to improve oral hygiene in patients with periodontal diseases: A systematic review. Journal of Clinical Periodontology, 47, 72-89.
11. Cher, B. A., Morden, N. E., & Meara, E. (2019). Medicaid expansion and prescription trends: opioids, addiction therapies, and other drugs. Medical care, 57(3), 208-212.
12. Conway, K. P., Swendsen, J., Husky, M. M., He, J. P., & Merikangas, K. R. (2016). Association of lifetime mental disorders and subsequent alcohol and illicit drug use: results from the National Comorbidity Survey–Adolescent Supplement. Journal of the American Academy of Child & Adolescent Psychiatry, 55(4), 280-288.
13. Cooper, R. (2018). Diagnosing the diagnostic and statistical manual of mental disorders. Routledge.
14. Csete, J., Kamarulzaman, A., Kazatchkine, M., Altice, F., Balicki, M., Buxton, J., ... & Beyrer, C. (2016). Public health and international drug policy. The Lancet, 387(10026), 1427-1480.
15. Davis, D. R., Kurti, A. N., Skelly, J. M., Redner, R., White, T. J., & Higgins, S. T. (2016). A review of the literature on contingency management in the treatment of substance use disorders, 2009–2014. Preventive medicine, 92, 36-46.
16. Deak, J. D., & Johnson, E. C. (2021). Genetics of substance use disorders: a review. Psychological medicine, 51(13), 2189-2200.
17. Easton, C. J., Crane, C. A., & Mandel, D. (2018). A randomized controlled trial assessing the efficacy of cognitive behavioral therapy for substance‐dependent domestic violence offenders: an integrated substance abuse‐domestic violence treatment approach (SADV). Journal of marital and family therapy, 44(3), 483-498.
18. Fernandes, R. M., Cary, M., Duarte, G., Jesus, G., Alarcão, J., Torre, C., ... & Carneiro, A. V. (2017). Effectiveness of needle and syringe Programmes in people who inject drugs–An overview of systematic reviews. BMC Public Health, 17, 1-15.
19. Florence, C. S., Zhou, C., Luo, F., & Xu, L. (2016). The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Medical care, 54(10), 901-906.
20. Friedmann, P. D., Wilson, D., Knudsen, H. K., Ducharme, L. J., Welsh, W. N., Frisman, L., ... & Vocci, F. J. (2015). Effect of an Organizational linkage Intervention on Staff perceptions of medication-assisted treatment and Referral Intentions in community corrections. Journal of substance abuse treatment, 50, 50-58.
21. Ghany, M. G., Morgan, T. R., & AASLD‐IDSA hepatitis C guidance panel. (2020). Hepatitis C guidance 2019 update: American Association for the Study of Liver Diseases–Infectious Diseases Society of America recommendations for testing, managing, and treating hepatitis C virus infection. Hepatology, 71(2), 686-721.
22. Goldman, D., Ducci, F., & Gitik, M. (2020). Familial genetics of psychopathic disorders. The Wiley international handbook on psychopathic disorders and the law, 159-187.
23. Gordon, A. J., Drexler, K., Hawkins, E. J., Burden, J., Codell, N. K., Mhatre-Owens, A., ... & Hagedorn, H. (2020). Article commentary: stepped care for opioid use disorder train the trainer (SCOUTT) initiative: expanding access to medication treatment for opioid use disorder within veterans health administration facilities. Substance Abuse, 41(3), 275-282.
24. Grant, B. F., Chou, S. P., Saha, T. D., Pickering, R. P., Kerridge, B. T., Ruan, W. J., ... & Hasin, D. S. (2017). Prevalence of 12-month alcohol use, high-risk drinking, and DSM-IV alcohol use disorder in the United States, 2001-2002 to 2012-2013: results from the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA psychiatry, 74(9), 911-923.
25. Hartman, C. A., Larsson, H., Vos, M., Bellato, A., Libutzki, B., Solberg, B. S., ... & Reif, A. (2023). Anxiety, mood, and substance use disorders in adult men and women with and without attention-deficit/hyperactivity disorder: a substantive and methodological overview. Neuroscience & Biobehavioral Reviews, 151, 105209.Huskamp, H. A., Busch, A. B., Souza, J., Uscher-Pines, L., Rose, S., Wilcock, A., ... & Mehrotra, A. (2018). How is telemedicine being used in opioid and other substance use disorder treatment?? Health Affairs, 37(12), 1940-1947.
26. Helle, A. C., Boness, C. L., & Sher, K. J. (2022). College students’ receptiveness to intervention approaches for alcohol and cannabis use. Psychology of Addictive Behaviors, 36(2), 157.
27. Hennessy, E. A., & Tanner-Smith, E. E. (2015). Effectiveness of brief school-based interventions for adolescents: A meta-analysis of alcohol use prevention programs. Prevention Science, 16, 463-474.
28. Jones, J. D., Comer, S. D., & Kranzler, H. R. (2015). The pharmacogenetics of alcohol use disorder. Alcoholism: Clinical and Experimental Research, 39(3), 391-402.
29. Kamens, H. M., Cramer, S., Hanley, R. N., Chase, S., Wickenheisser, A., Horton, W. J., & Zhang, N. (2023). Neuroimaging of opioid exposure: a review of preclinical animal models to inform addiction research. Psychopharmacology, 240(12), 2459-2482.
30. Kaufmann, C. P., Stämpfli, D., Hersberger, K. E., & Lampert, M. L. (2015). Determination of risk factors for drug-related problems: a multidisciplinary triangulation process. BMJ open, 5(3), e006376.
31. Kim, K. (2015). The processing and treatment of mentally ill persons in the criminal justice system.
32. Lesch, O. M., Walter, H., Wetschka Ch, H. M., & Hesselbrock, V. (2020). Alcohol and tobacco. Springer International Publishing.
33. Lin, L. A., Casteel, D., Shigekawa, E., Weyrich, M. S., Roby, D. H., & McMenamin, S. B. (2019). Telemedicine-delivered treatment interventions for substance use disorders: A systematic review. Journal of substance abuse treatment, 101, 38-49.
34. Magill, M., Ray, L., Kiluk, B., Hoadley, A., Bernstein, M., Tonigan, J. S., & Carroll, K. (2019). A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition. Journal of consulting and clinical psychology, 87(12), 1093.
35. Marie-Claire, C., Jourdaine, C., Lépine, J. P., Bellivier, F., Bloch, V., & Vorspan, F. (2017). PhPharmacogenomicsf of opiates and methadone maintenance treatment: Current data and perspectives. Pharmacogenomics, 18(14), 1359-1372.
36. McElrath, K. (2018). Medication-assisted treatment for opioid addiction in the United States: Critique and commentary. Substance Use & Misuse, 53(2), 334-343.
37. Memedovich, K. A., Dowsett, L. E., Spackman, E., Noseworthy, T., & Clement, F. (2018). The adverse health effects and harms related to marijuana use: an overview review. Canadian Medical Association Open Access Journal, 6(3), E339-E346.
38. Memedovich, K. A., Dowsett, L. E., Spackman, E., Noseworthy, T., & Clement, F. (2018). The adverse health effects and harms related to marijuana use: an overview review. Canadian Medical Association Open Access Journal, 6(3), E339-E346.
39. Mercer Lindsay, N., Chen, C., Gilam, G., Mackey, S., & Scherrer, G. (2021). Brain circuits for pain and its treatment. Science translational medicine, 13(619), eabj7360.Carroll, K. M., & Kiluk, B. D. (2017). Cognitive behavioral interventions for alcohol and drug use disorders: Through the stage model and back again. Psychology of addictive behaviors, 31(8), 847.
40. Miller, W. R., & Moyers, T. B. (2017). Motivational interviewing and the clinical science of Carl Rogers. Journal of consulting and clinical psychology, 85(8), 757.
41. Miller, W. R., & Rollnick, S. (2024). Why motivational interviewing is a person-centered approach. Sucht.
42. Misra, S., Jackson, V. W., Chong, J., Choe, K., Tay, C., Wong, J., & Yang, L. H. (2021). Systematic review of cultural aspects of stigma and mental illness among racial and ethnic minority groups in the United States: Implications for interventions. American journal of community psychology, 68(3-4), 486-512.
43. Naslund, J. A., Aschbrenner, K. A., Marsch, L. A., & Bartels, S. J. (2016). The future of mental health care: peer-to-peer support and social media. Epidemiology and psychiatric sciences, 25(2), 113-122.
44. Needle, R. H., Burrows, D., Friedman, S. R., Dorabjee, J., Touzé, G., Badrieva, L., ... & Latkin, C. (2017). Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users. In Drug Abuse: Prevention and Treatment (pp. 189-201). Routledge.
45. Ng, J., Sutherland, C., & Kolber, M. R. (2017). Does evidence support supervised injection sites? Canadian Family Physician, 63(11), 866-866.
46. Oesterle, T. S., Thusius, N. J., Rummans, T. A., & Gold, M. S. (2019, October). Medication-assisted treatment for opioid-use disorder. In Mayo Clinic Proceedings (Vol. 94, No. 10, pp. 2072-2086). Elsevier.
47. Passmore, J., & Whybrow, A. (2019). Motivational interviewing. The handbook of coaching psychology. London: Brunner-Routledge.
48. Petry, N. M., Alessi, S. M., Olmstead, T. A., Rash, C. J., & Zajac, K. (2017). Contingency management treatment for substance use disorders: How far has it come, and where does it need to go? Psychology of Addictive Behaviors, 31(8), 897.
49. Platt, L., Minozzi, S., Reed, J., Vickerman, P., Hagan, H., French, C., ... & Hickman, M. (2018). Needle and syringe programs and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis. Addiction, 113(3), 545-563.
50. Ray, L. A., Meredith, L. R., Kiluk, B. D., Walthers, J., Carroll, K. M., & Magill, M. (2020). Combined pharmacotherapy and cognitive behavioral therapy for adults with alcohol or substance use disorders: a systematic review and meta-analysis. JAMA Network open, 3(6), e208279-e208279.
51. Rueda, S., Mitra, S., Chen, S., Gogolishvili, D., Globerman, J., Chambers, L., ... & Rourke, S. B. (2016). Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses. BMJ open, 6(7), e011453.
52. Tostes, J. G. D. A., Dias, R. T., Reis, A. A. D. S., Silveira, P. S. D., & Ronzani, T. M. (2020). Interventions to reduce stigma related to people who use drugs: systematic review. Paidéia (Ribeirão Preto), 30, e3022.
53. Tracy, K., & Wallace, S. P. (2016). Benefits of peer support groups in the treatment of addiction. Substance abuse and rehabilitation, 143-154.
54. Volkow, N. D., Michaelides, M., & Baler, R. (2019). The neuroscience of drug reward and addiction. Physiological reviews, 99(4), 2115-2140.
55. Wardell, J. D., Cunningham, J. A., Quilty, L. C., Carter, S., & Hendershot, C. S. (2020). Can the AUDIT consumption items distinguish lower severity from high severity patients seeking treatment for alcohol use disorder? Journal of Substance Abuse Treatment, 114, 108001.
Published
2024-01-09
How to Cite
Priya Sharma. (2024). Prevention and intervention strategies for substance use disorder. Revista Electronica De Veterinaria, 25(1), 3261-3271. https://doi.org/10.69980/redvet.v25i1.1547
Section
Articles